Field Trip Health Ltd. obtains conditional approval for its update on the Toronto Stock Exchange
Enter Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
TORONTO, May 27, 2021 (GLOBE NEWSWIRE) – Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“Excursion“), a leader in the development and delivery of psychedelic therapies, is pleased to announce that it has received conditional approval to list its common shares and warrants on the Toronto Stock Exchange (TSX). Listing is conditional on the Company meeting certain requirements of the TSX in accordance with the terms of its conditional approval letter dated May 26, 2021.
Field Trip is actively working to meet the requirements and conditions that were outlined in the approval letter and management is confident that all registration requirements will be met in the coming weeks. After obtaining final approval, the company will issue an additional press release to notify shareholders when it expects its common shares to begin trading on the TSX.
Once the final listing requirements are met, the Company’s common shares will be delisted from the CSE and will begin trading on the TSX under the symbol “FTRP” and the warrants will trade under the symbol “FTRP- WT ”. The Company’s shares will continue to trade on the OTCQX market under the symbol “FTRPF”.
Joseph del Moral, CEO of Field Trip, said: “Receiving conditional acceptance to move to Canada’s largest stock exchange is a milestone for Field Trip and for the emerging psychedelic industry in general. While our TSX listing will provide greater visibility for Field Trip in the markets and expand our access to other Canadian and international investors, we continue to work on improving liquidity for global investors in Field Trip, including by exploring cross-listings on US stock exchanges. . “
About Field Trip Health Ltd.
Field Trip is a global leader in the development and delivery of psychedelic therapies. With our Field Trip Discovery division leading the development of the next generation of psychedelic molecules and leading advanced research on herbal psychedelics and our Field Trip Health division building centers for psychedelic therapies in North America and Europe as well as digital and technological tools that will enable on a massive scale, we are helping those in need with a simple, factual way to heal and strengthen engagement with the world.
Follow us on Twitter and Instagram: @fieldtriphealth
To receive company updates on Field Trip and to be added to the email distribution list, please subscribe here.
For more information, contact Ronan Levy, Executive Chairman and Director of Field Trip, at 1 (833) 833-1967.
Caution regarding forward-looking information.
This press release contains forward-looking information within the meaning of Canadian securities laws regarding Field Trip and its activities, which may include, but are not limited to, statements relating to Field Trip’s intended use of the proceeds of the offering. Often, but not always, forward-looking information can be identified by the use of words such as “expect”, “intend”, “anticipate”, “believe” or variations (including negative variations) of these words and expressions, or indicate that certain actions, events or results “may”, “could”, “would” or “will” be undertaken, will occur or will be achieved. These statements are based on the current expectations and opinions on future events of the management of Field Trip, and are based on assumptions and subject to risks and uncertainties. Although the management of Field Trip believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially due to known and unknown risk factors and uncertainties affecting businesses, including risks regarding the COVID-19 outbreak, the medical clinic industry, market conditions, economics, management’s ability to manage and operate the business and the stock markets in general. Although Field Trip has attempted to identify material factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or or results differ from those expected, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking statements or information. No forward-looking statement can be guaranteed. Unless required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Field Trip undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
Neither the Canadian Securities Exchange, nor the Toronto Stock Exchange, nor their regulatory services provider, nor the over-the-counter markets have approved the contents of this press release nor accept responsibility for the adequacy or the adequacy of this release. accuracy of this release.
Media contacts:Rachel Moskowitz Fall Communications202-276-7881[email protected]
Nick Opich / McKenna MillerKCSA Strategic Communications212-896-1206 / 347-487-6197[email protected]
Ania Gilbert – Canadian MediaPomp & Circumstance647-273-9869[email protected]
Investor contacts:Elizabeth BarkerKCSA Strategic Communications212-896-1203[email protected]
SOURCE Field Trip Health Ltd.
Source: Field Trip Health, Ltd.